R D Johnson1, M L O'Connor, R M Kerr. 1. Department of Pathology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina, USA.
Abstract
OBJECTIVE: To determine the frequency, etiology, and associated mortality of extreme elevations of serum AST. METHODS: The medical records were reviewed of all patients with a serum AST over 3000 U/L during 1 full calendar year at a large, tertiary-care hospital. Serum AST, with an upper limit of normal at 35 U/L, is included in the automated, 18-test chemistry profile run on virtually all clinically ill patients admitted to this hospital. RESULTS: Of 23,125 admissions, 56 patients had or developed serum AST concentrations greater than 3000 U/L, an occurrence rate of approximately two per 1000 admissions. Either liver or skeletal muscle was the origin of virtually all such AST elevations. Acute hypotension (ischemic or hypoxic hepatitis) accounted for the majority (29/56) of the cases; toxic (seven) or viral (four) hepatitis together accounted for 11/56 cases. Overall mortality, on this admission, was 31/56 (55%). CONCLUSIONS: Extreme elevations of AST are most often attributable to hypoxic hepatitis. Patients with extreme AST due to hypoxic hepatitis had a 22/29 (75%) mortality compared with 9/27 (33%) for all other causes combined.
OBJECTIVE: To determine the frequency, etiology, and associated mortality of extreme elevations of serum AST. METHODS: The medical records were reviewed of all patients with a serum AST over 3000 U/L during 1 full calendar year at a large, tertiary-care hospital. Serum AST, with an upper limit of normal at 35 U/L, is included in the automated, 18-test chemistry profile run on virtually all clinically ill patients admitted to this hospital. RESULTS: Of 23,125 admissions, 56 patients had or developed serum AST concentrations greater than 3000 U/L, an occurrence rate of approximately two per 1000 admissions. Either liver or skeletal muscle was the origin of virtually all such AST elevations. Acute hypotension (ischemic or hypoxic hepatitis) accounted for the majority (29/56) of the cases; toxic (seven) or viral (four) hepatitis together accounted for 11/56 cases. Overall mortality, on this admission, was 31/56 (55%). CONCLUSIONS: Extreme elevations of AST are most often attributable to hypoxic hepatitis. Patients with extreme AST due to hypoxic hepatitis had a 22/29 (75%) mortality compared with 9/27 (33%) for all other causes combined.
Authors: Valentin Fuhrmann; Nikolaus Kneidinger; Harald Herkner; Gottfried Heinz; Mariam Nikfardjam; Anja Bojic; Peter Schellongowski; Bernhard Angermayr; Maximilian Schöniger-Hekele; Christian Madl; Peter Schenk Journal: Intensive Care Med Date: 2011-06-07 Impact factor: 17.440
Authors: Trivendra Tripathi; Mohammad Shahid; Haris M Khan; Rahat Ali Khan; Mashiatullah Siddiqui; Abbas Ali Mahdi Journal: Saudi J Biol Sci Date: 2011-08-05 Impact factor: 4.219
Authors: Valentin Fuhrmann; Nikolaus Kneidinger; Harald Herkner; Gottfried Heinz; Mariam Nikfardjam; Anja Bojic; Peter Schellongowski; Bernhard Angermayr; Reinhard Kitzberger; Joanna Warszawska; Ulrike Holzinger; Peter Schenk; Christian Madl Journal: Intensive Care Med Date: 2009-06-09 Impact factor: 17.440
Authors: Astrid Van den Broecke; Laura Van Coile; Alexander Decruyenaere; Kirsten Colpaert; Dominique Benoit; Hans Van Vlierberghe; Johan Decruyenaere Journal: Ann Intensive Care Date: 2018-01-30 Impact factor: 6.925